October 20, 2016

Patient Access Network Foundation and the Cutaneous Lymphoma Foundation announce new alliance to provide support for people living with cutaneous T-cell lymphoma

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Washington, DC, (October 20, 2016) – The Patient Access Network (PAN) Foundation and the Cutaneous Lymphoma Foundation (CLF) today announced they are launching a new alliance to offer a broad range of support for people living with cutaneous T-cell lymphoma. Working together, the PAN Foundation and the CLF will ensure that people living with cutaneous T-cell lymphoma have access to helpful resources and both patient and financial support services, providing them with the holistic support to best manage their disease.

“Here at PAN, our goal is to provide financial support to patients facing diseases like cutaneous T-cell lymphoma,” said PAN President and CEO Dan Klein. “Our partnership with the Cutaneous Lymphoma Foundation helps us take that support a step further, by connecting patients and families to enhanced services like personalized support, in-person networking groups, an online learning center and live educational events.”

Cutaneous lymphomas, a subset of non-Hodgkin’s lymphoma, are cancers of lymphocytes (white blood cells) that primarily involve the skin, according to the Cutaneous Lymphoma Foundation. Classification is based on lymphocyte type: B-lymphocytes (B-cell) or T-lymphocytes (T-cell). Cutaneous T-cell lymphoma is the most common type of cutaneous lymphoma.

“We are thrilled to work with PAN and expand our services to our patients and their families,” said CLF CEO Susan Thornton. “A cutaneous T-cell lymphoma diagnosis is understandably overwhelming for patients and their loved ones. Our partnership with PAN allows us to help alleviate some of the financial pressures so they can focus on what matters most—their health.”

Patients who qualify for the PAN Foundation’s cutaneous T-cell lymphoma program are eligible to receive up to $20,000 per year in financial assistance. Eligible patients must be getting treatment for cutaneous T-cell lymphoma; must reside and receive treatment in the United States; must have health insurance; and the medication for which they seek assistance must be covered by their health insurance and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

About the Cutaneous Lymphoma Foundation:

The Cutaneous Lymphoma Foundation is an independent, non-profit patient advocacy organization dedicated to supporting every person affected by cutaneous lymphoma by promoting awareness and education, advancing patient care and fostering research for the best possible outcomes. For more information, visit clfoundation.org or call 1-248-644-9014.